Handheld X-ray device maker OXOS Medical scores $23M

1 minute, 48 seconds Read

[ad_1]

Healthcare imaging business OXOS Healthcare scored $23 million in Sequence A funding from Intel Money and Parkway Venture Money, bringing its complete increase to $45 million. 

Gregg Hill, Parkway’s cofounder and taking care of companion, and Eric King, Intel Capital’s financial investment director, will be a part of OXOS’ board of directors. 

WHAT THEY DO

The Atlanta-primarily based firm features an Food and drug administration 510(k)-cleared handheld X-ray process that can be employed for static and serial diagnostic photographs of the extremities, dubbed the Micro C Professional medical Imaging Program. The unit connects specifically to OXOS’ cloud platform, wherever medical professionals can entry pictures.

The money will be applied to grow the company’s solution availability around the globe and pace up solution innovation. 

“At OXOS, we have produced it our mission to shut the expanding healthcare divide – the inaccessibility of radiographic technological innovation is impairing affected individual results in each and every corner of the world,” Evan Ruff, cofounder and CEO of OXOS, reported in a assertion.

“We purpose to set secure, effective, and simple X-ray technologies in the fingers of urgent care facilities, sports teams, home care, and worldwide mission functions, exactly where a true-time analysis is critical to saving human life.”

Marketplace SNAPSHOT

OXOS initially received Fda clearance for its Micro C Technique in 2021. Past calendar year, it acquired a different Fda 510(k) clearance for the device that provided its AiLARA Technique, an AI-automatic radiation dosage engine.

Accessing imaging in lower- to middle-revenue nations around the world can be tough. OXOS is pitching its unit as a way to allow additional people throughout the world to access X-ray imaging technology.

Another enterprise working to make imaging units much more transportable is Philips, which produced Lumify, a handheld ultrasound transducer that can be plugged into a smartphone or a tablet and brought to a patient’s bedside. 

Darren Mann, Kathryn Kuttler and Dr. Peter Haug will supply additional element in the course of the HIMSS23 session “Enhanced Individual Care Enabled by Actual-Time Interoperable Medical Decision Assist.” It is schedule for Thursday, April 20 at 4 p.m. – 5 p.m. CT at the South Creating, Degree 1, room S105 C.

[ad_2]

Resource url

Similar Posts